Literature DB >> 10679261

Heme metabolism of Plasmodium is a major antimalarial target.

G Padmanaban1, P N Rangarajan.   

Abstract

The malarial parasite manifests unique features of heme metabolism. In the intraerythrocyte stage it utilizes the host hemoglobin to generate amino acids for its own protein synthesis, but polymerizes the acquired heme as a mechanism for detoxification. At the same time the parasite synthesizes heme de novo for metabolic use. The heme biosynthetic pathway of the parasite is similar to that of hepatocytes and erythrocytes. However, while the parasite makes its own delta-aminolevulinate (ALA) synthase that is immunochemically different from that of the host, it imports ALA dehydrase and perhaps the subsequent enzymes of the pathway from the host red cell. Many schizonticidal drugs such as chloroquine and artemisinin act by interfering with the heme metabolism of the parasite and there is scope to design new molecules based on the unique features of this metabolic machinery in the parasite. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679261     DOI: 10.1006/bbrc.1999.1892

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Mechanism of malarial haem detoxification inhibition by chloroquine.

Authors:  A V Pandey; H Bisht; V K Babbarwal; J Srivastava; K C Pandey; V S Chauhan
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  Proteobacteria-like ferrochelatase in the malaria parasite.

Authors:  Shigeharu Sato; R J M Wilson
Journal:  Curr Genet       Date:  2003-01-18       Impact factor: 3.886

3.  The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages.

Authors:  Hangjun Ke; Paul A Sigala; Kazutoyo Miura; Joanne M Morrisey; Michael W Mather; Jan R Crowley; Jeffrey P Henderson; Daniel E Goldberg; Carole A Long; Akhil B Vaidya
Journal:  J Biol Chem       Date:  2014-10-28       Impact factor: 5.157

4.  Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.

Authors:  Clare M Smith; Ante Jerkovic; Hervé Puy; Ingrid Winship; Jean-Charles Deybach; Laurent Gouya; Giel van Dooren; Christopher Dean Goodman; Angelika Sturm; Hana Manceau; Geoffrey Ian McFadden; Peter David; Odile Mercereau-Puijalon; Gaétan Burgio; Brendan J McMorran; Simon J Foote
Journal:  Blood       Date:  2014-11-20       Impact factor: 22.113

5.  Role of heme and heme-proteins in trypanosomatid essential metabolic pathways.

Authors:  Karina E J Tripodi; Simón M Menendez Bravo; Julia A Cricco
Journal:  Enzyme Res       Date:  2011-04-10

6.  Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and FE(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry.

Authors:  Vlada A Pashynska; Hilde Van den Heuvel; Magda Claeys; Marina V Kosevich
Journal:  J Am Soc Mass Spectrom       Date:  2004-08       Impact factor: 3.109

7.  Structure of the heme biosynthetic Pseudomonas aeruginosa porphobilinogen synthase in complex with the antibiotic alaremycin.

Authors:  Ilka U Heinemann; Claudia Schulz; Wolf-Dieter Schubert; Dirk W Heinz; Yang-G Wang; Yuichi Kobayashi; Yuuki Awa; Masaaki Wachi; Dieter Jahn; Martina Jahn
Journal:  Antimicrob Agents Chemother       Date:  2009-10-12       Impact factor: 5.191

8.  Modeling of human M1 aminopeptidases for in silico screening of potential Plasmodium falciparum alanine aminopeptidase (PfA-M1) specific inhibitors.

Authors:  Shakti Sahi; Sneha Rai; Meenakshi Chaudhary; Vikrant Nain
Journal:  Bioinformation       Date:  2014-08-30

9.  Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy.

Authors:  Margarida Cunha-Rodrigues; Sílvia Portugal; Miguel Prudêncio; Lígia A Gonçalves; Cristina Casalou; Dominik Buger; Robert Sauerwein; Werner Haas; Maria M Mota
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

10.  In silico designing and molecular docking of a potent analog against Staphylococcus aureus porphobilinogen synthase.

Authors:  Pasupuleti Santhosh Kumar; Yellapu Nanda Kumar; Uppu Venkateswara Prasad; Sthanikam Yeswanth; Vimjam Swarupa; Gopal Sowjenya; Katari Venkatesh; Lokanathan Srikanth; Valasani Koteswara Rao; Potukuchi Venkata Gurunatha Krishna Sarma
Journal:  J Pharm Bioallied Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.